Related Experiment Video
Updated: May 25, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
Molecular interactions of Alzheimer's Aβ protofilaments with lipid membranes
Florentina Tofoleanu1, Nicolae-Viorel Buchete
1School of Physics, University College Dublin, Belfield, Dublin 4, Ireland.
Abstract:
Amyloid fibrils and peptide oligomers play central roles in the pathology of Alzheimer's disease, type 2 diabetes, Parkinson's disease, Huntington's disease, and prion-related disease. Here, we investigate the molecular interactions between preformed amyloid β (Aβ) molecular protofilaments and lipid bilayer membranes, in the presence of explicit water molecules, using computational models and all-atom molecular dynamics. These interactions play an important role in the stability and function of both Aβ fibrils and the adjacent cellular membrane. Taking advantage of the symmetry-related and directional properties of the protofilaments, we build models that cover several relative protofilament-membrane orientations. Our molecular dynamics simulations reveal the relative contributions of different structural elements to the dynamics and stability of Aβ protofilament segments near membranes, and the first steps in the mechanism of fibril-membrane interactions. During this process, we observe a significant alteration of the side-chain contact pattern in protofilaments, although a fraction of the characteristic β-sheet content is preserved. As a major driving force, we identify the electrostatic interactions between Aβ charged side chains, including E22, D23, and K28, and lipid headgroups. Together with hydrogen bonding with atoms from lipid headgroups, these interactions can facilitate the penetration of hydrophobic C-terminal amino acids through the lipid headgroup region, which can finally lead both to further loss of the initial fibril structure and to local membrane-thinning effects. Our results may guide new experiments that could test the extent to which the structural features of water-formed amyloid fibrils are preserved, lost, or reshaped by membrane-mediated interactions.
Insights
Interactions between amyloid beta (Aβ) protofilaments and lipid membranes disrupt fibril structure and thin membranes. Electrostatic forces between Aβ and lipid headgroups drive these damaging interactions, impacting neurodegenerative disease pathology.
Area of Science:
- Biophysics
- Computational Biology
- Neuroscience
Background:
- Amyloid fibrils and peptide oligomers are implicated in major neurodegenerative diseases.
- Understanding amyloid-membrane interactions is crucial for disease pathology.
Purpose of the Study:
- Investigate molecular interactions between amyloid beta (Aβ) protofilaments and lipid bilayer membranes.
- Elucidate the role of these interactions in fibril stability and membrane function.
Main Methods:
- Computational modeling and all-atom molecular dynamics simulations.
- Simulations included explicit water molecules and various protofilament-membrane orientations.
Main Results:
- Observed significant alterations in protofilament side-chain contacts, with partial preservation of β-sheet structure.
- Identified electrostatic interactions between Aβ charged residues (E22, D23, K28) and lipid headgroups as a major driving force.
- Documented penetration of hydrophobic C-terminal amino acids, leading to fibril structure loss and membrane thinning.
Conclusions:
- Membrane interactions reshape amyloid fibril structure and affect membrane integrity.
- Electrostatic forces and hydrogen bonding are key mediators of fibril-membrane interactions.
- Findings may inform experimental studies on amyloid fibril behavior at membrane interfaces.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer's Disease: Treatment

